Critic-aid Clear Ointment
NDC Package 11701-083-22
Package Information
Critic-aid Clear (petrolatum) ointment is clean the affected area and dry thoroughly.Knead before use.Apply a thin layer liberally enough to cover yet visualize the skin.Apply to the affected area twice daily (morning and night), or as directed by a doctor.Supervise children in the use of this product. This formulation utilizes a ointment delivery system. Marketed by Coloplast Corp, this product is identified by NDC 11701-083 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 2383008 - petrolatum 86.5 % Topical Ointment
- RxCUI: 2383008 - petrolatum 0.865 MG/MG Topical Ointment
- RxCUI: 2677087 - Critic-Aid Clear Moisture 86.5 % Topical Ointment
- RxCUI: 2677087 - petrolatum 0.865 MG/MG Topical Ointment [Critic-Aid Clear Moisture]
- RxCUI: 2677087 - Critic-Aid Clear Moisture 0.865 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11701 - Coloplast Corp
- 11701-083 - Critic-aid Clear
- 11701-083-22 - 4 g in 1 PACKET
- 11701-083 - Critic-aid Clear
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11701-083). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11701-083-22 identifies a specific commercial package of 4 g in 1 packet of Critic-aid Clear, a human over the counter drug labeled by Coloplast Corp. This ointment is formulated for topical use and contains petrolatum as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Coloplast Corp on January 22, 2019. The current certification is valid through December 31, 2027.
How is this Coloplast Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11701008322. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.